Pozelimab, a human monoclonal antibody against complement factor c5, provided inhibition of intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria

Authors
Category Primary study
JournalBlood
Year 2021
This article has no abstract
Epistemonikos ID: 9806e3ca109b3834e9f1ebd61c81ceacd3d475c6
First added on: Feb 13, 2025